Cocrystal Pharma Inc. (COCP)

First Results From Influenza Program Announced


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
April 13, 2022
Report ID: 24716
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$2.63 1.54%
Market Cap
$21.4M
Price Target
Refer to Report
Volume
24.2K
52wk Range
$2.0501 - $11.6568
Related Research Reports
11/16/2022

3Q22 Reported – First Influenza Vaccine Data To Be Presented
3Q22 Reported – First Influenza Vaccine Data To Be Presented (COCP)
9/12/2022

Influenza Program Update
Influenza Program Update (COCP)
8/16/2022

2Q Reported With Influenza and COVID-19 Product Updates
2Q Reported With Influenza and COVID-19 Product Updates (COCP)
5/12/2022

Influenza Trial Continues With New Clinical Trials Planned For COVID-19
Influenza Trial Continues With New Clinical Trials Planned For COVID-19 (COCP)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.